ID: ALA4168560

Max Phase: Preclinical

Molecular Formula: C48H56N8O5

Molecular Weight: 825.03

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1cn(C)c2ccccc12)C(=O)N[C@@H](CC(C)C)C(N)=O

Standard InChI:  InChI=1S/C48H56N8O5/c1-30(2)23-38(44(49)57)52-47(60)42(27-34-29-56(4)43-22-14-12-20-36(34)43)55-46(59)40(25-32-17-9-6-10-18-32)53-48(61)41(26-33-28-51-37-21-13-11-19-35(33)37)54-45(58)39(50-3)24-31-15-7-5-8-16-31/h5-22,28-30,38-42,50-51H,23-27H2,1-4H3,(H2,49,57)(H,52,60)(H,53,61)(H,54,58)(H,55,59)/t38-,39+,40-,41+,42+/m0/s1

Standard InChI Key:  UGKJHIFSCKUAKA-CTLZPSQBSA-N

Associated Targets(Human)

NCI-H69 709 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DMS-79 150 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 825.03Molecular Weight (Monoisotopic): 824.4374AlogP: 3.99#Rotatable Bonds: 20
Polar Surface Area: 192.24Molecular Species: NEUTRALHBA: 7HBD: 7
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.94CX Basic pKa: 8.34CX LogP: 5.20CX LogD: 4.21
Aromatic Rings: 6Heavy Atoms: 61QED Weighted: 0.06Np Likeness Score: -0.05

References

1. Haitham Abusara O, Freeman S, Aojula HS..  (2017)  Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain.,  137  [PMID:28595067] [10.1016/j.ejmech.2017.05.053]

Source